KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Staar Surgical (STAA) EPS (Weighted Average and Diluted) (2016 - 2026)

Staar Surgical's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at -$0.36 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 47.83% year-over-year to -$0.36; the TTM value through Jan 2026 reached -$1.62, down 295.12%, while the annual FY2026 figure was -$1.62, 295.12% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.36 in Q1 2026 per STAA's latest filing, down from $0.18 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.26 in Q3 2022 to a low of -$1.1 in Q1 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.05, with a median of $0.12 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 100.0% in 2024, then tumbled 1471.43% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.13 in 2022, then rose by 23.08% to $0.16 in 2023, then plummeted by 531.25% to -$0.69 in 2024, then skyrocketed by 126.09% to $0.18 in 2025, then tumbled by 300.0% to -$0.36 in 2026.
  • Per Business Quant, the three most recent readings for STAA's EPS (Weighted Average and Diluted) are -$0.36 (Q1 2026), $0.18 (Q3 2025), and -$0.34 (Q2 2025).